Skoči na glavni sadržaj

Izlaganje sa skupa

WEIGHT GAIN INDUCED WITH OLANZAPINE IN ADOLESCENT

Mirjana Graovac ; University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Rijeka, Croatia
Klementina Ružić ; University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Rijeka, Croatia
Jelena Rebić ; University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Rijeka, Croatia
Elizabeta Dadić-Hero ; Department of Social Medicine and Epidemiology, School of Medicine, Rijeka, Croatia
Ana Kaštelan ; University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Rijeka, Croatia
Tanja Frančišković ; University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Rijeka, Croatia


Puni tekst: engleski pdf 195 Kb

str. 101-104

preuzimanja: 609

citiraj


Sažetak

Children and adolescents are being treated with antipsychotics more often than before, although the risk of adverse events in this
age group still remains unclear.
Because of increased use of antipsychotics in children and adolescents, their endocrine and metabolic side-effects (weight gain,
obesity, and related metabolic deviations) are of particular worrying, especially within pediatric and adolescent population that
appears to be at greater risk comparing with adults for antipsychotic-induced metabolic adverse events.
In this work we will present the course of treatment of an adolescent girl with psychotic symptoms, within the clinical diagnosis
of Organic delusional disorder, who had a considerable weight gain after one year of olanzapine treatment.

Ključne riječi

olanzapine; weight gain; adolescence

Hrčak ID:

76545

URI

https://hrcak.srce.hr/76545

Datum izdavanja:

31.3.2011.

Posjeta: 1.254 *